2019 Publications

Here is a complete list of Lab publications on PubMed

The power of human cancer genetics as revealed by low-grade gliomas
Jones DTW, Bandopadhayay P, Jabado N
Annu Rev Genet (2019) Dec 3. doi: 10.1146/annurev-genet-120417-031642. [Epub ahead of print]

Longitudinal molecular trajectories of diffuse glioma in adults
GLASS Consortium
Nature (2019) Nov 20. doi: 10.1038/s41486-019-1775-1. [Epub ahead of print]

Increasing value of autopsies in patients with brain tumors in the molecular era
Ahrendsen JT, Filbin MG, Chi SN, Manley PE, Wright KD, Bandopadhayay P, Clymer JR, Yeo KK, Kieran MW, Jones R, Lidov HG, Ligon KL, Alexandrescu S
J Neurooncol (2019) Nov; 145(2):349-355.  doi 10.1007/s11060-019-03302-z. Epub 2019 Sep30. 

Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells
Reitman ZJ, Paolella BR, Bergthold G, Pelton K, Becker S, Jones R, Sinai CE, Malkin H, Huang Y, Grimmet L, Herbert ZT, Sun Y, Weatherbee JL, Alberta JA, Daley JF, Rozenblatt-Rosen O, Condurat AL, Qian K, Khadka P, Segal RA, Haas-Kogan D, Filbin MG, Suva ML, Regev A, Stiles CD, Kieran MW, Goumnerova L, Ligon KL, Shalek AK, Bandopadhayay P#, Beroukhim R#
Nat Commun (2019): Aug 19; 10(1):3731.  doi 10.1038/s41467-019-11493-2. 

Boston Children’s Hospital Research Discovery blog here

Towards Immunotherapy for Pediatric Brain Tumors
Wang SS, Bandopadhayay P, Jenkins MR
Trends Immunol (2019): Jun 19. S1471-4906(19)30123-1. doi 10.1016/j.it.2019.05.009. [Epub ahead of print]

Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
Bandopadhayay P, Piccioni F, O’Rourke R, Ho P, Gonzalez EM, Buchan G, Qian K, Gionet G, Girard E, Coxon M, Rees MG, Brenan L, Dubois F, Shapira O, Greenwald NF, Pages M, Balboni Iniguez A, Paolella BR, Meng A, Sinai C, Roti G, Dharia NV, Creech A, Tanenbaum B, Khadka P, Tracy A, Tiv HL, Coy S, Rashid R, Lin JR, Cowley GS, Lam FC, Goodale A, Lee Y, Schoolcraft K, Vazquez F, Hahn WC, Tsherniak A, Bradner JE, Yaffe MB, Milde T, Pfister SM, Qi J, Schenone M, Carr SA, Ligon KL, Kieran MW, Santagata S, Olson JM, Gokhale PC, Jaffe JD, Root DE, Stegmaier K, Johannessen CM, Beroukhim R
Nature Comm (2019): Jun 3; 10(1). doi:10.1038/s41467-019-10307-9.

Featured in ‘Highlights from the Literature’ in Neuro-Oncology here

Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. 
Hong AL, Tseng YY, Wala JA, Kim WJ, Kynnap BD, Doshi MB, Kugener G, Sandoval GJ, Howard TJ, Li J, Yang X, Tillgren M, Ghandi M, Sayeed A, Deasy R, Ward A, McSteen B, Labella KM, Keskula P, Tracy A, Connor C, Clinton CM, Church AJ, Crompton BD, Janeway KA, Van Hare B, Sandak D, Gjoerup O, Bandopadhayay P, Clemons PA, Schreiber SL, Root DE, Gokhale PC, Chi SN, Mullen EA, Roberts CW, Kadoch C, Beroukhim R, Ligon KL, Boehm JS, Hahn WC.
Elife (2019): March 12;8. doi:10.7554/eLife 44161. [Epub ahead of print]

Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.
Miklja Z, Pasternak A, Stallard S, Nicolaides T, Kline-Nunnally C, Cole B, Beroukhim R, Bandopadhayay P, Chi S, Ramkissoon SH, Mullan B, Bruzek AK, Gauthier A, Garcia T, Atchison C, Marini B, Fouladi M, Parsons DW, Leary S, Mueller S, Ligon KL, Koschmann C
Neuro Oncol (2019): February 26. doi:10.1093/neuonc/noz022. [Epub ahead of print]

Comments are closed